Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

297

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

297 results for “young women”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Monitoring Pre-exposure Prophylaxis for Young Adult Women

ClinicalTrials.gov study NCT02915367. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
dryad36/100

Uptake of Human Papilloma Virus vaccine among young women living in fishing communities in Wakiso and Mukono districts, Uganda

<p>Human Papilloma Virus (HPV) is a preventable cause of cervical cancer, the most common cancer among women in Uganda. The Uganda Ministry of Health included the HPV vaccine in the free routine immunization schedule since 2015. Five years after this policy, we assessed the uptake of the HPV vaccine and associated socio-demographic factors among young women living in fishing communities in Central Uganda in 2020.</p> <p>We analyzed secondary data from 94 young women aged 9–25 years who were recruited from the two fishing communities (Kasenyi landing site and Koome Island) in a primary implementation study that aimed to promote awareness of maternal and childhood vaccines. We assessed uptake of the HPV vaccine as the proportion of participants who self-reported to have ever received at least one dose of the HPV vaccine. We assessed the socio-demographic factors associated with HPV vaccine uptake using a modified Poisson regression model adjusted for clustering by study site in STATA version 17.</p> <p>The mean (standard deviation) age of study participants was 21.1 (3.1) years and most (81.9%) of them were from Kasenyi landing site. The uptake of the HPV vaccine was 10.6% [95% Confidence Interval (CI) 5.6, 18.9].  After adjusting for covariates, being 20–25 years old (adjusted prevalence ratio [aPR] 0.18, 95%CI 0.06, 0.59) and of Catholic religion (aPR 5.55, 95%CI 1.53, 20.16) were significantly associated with HPV vaccine uptake. The HPV vaccine uptake was very low, despite the reported 99% national coverage of HPV vaccination program for the first dose at the end of 2019. Age and religion were shown to be important determinants of the HPV vaccine uptake. Reasons for very low uptake of HPV vaccinations need to be carefully assessed to find effective strategies to improve it.</p>

opencc-zeroJan 2024View details →
dryad36/100

Risky sexual behaviours and utilization of HIV testing services among the adolescent girls and young women aged between 15-24 years in Kibra Sub County, Nairobi County, Kenya

<p><strong>Introduction: </strong>HIV remains a significant global health challenge, disproportionately affecting adolescent girls and young women (AGYW). HIV testing is crucial in controlling the infection and reducing its prevalence. Understanding risky sexual behaviors among AGYW is pivotal in aligning prevention interventions. Despite global prevention efforts, testing gaps persist among AGYW, linked to risky sexual behavior (RSB). This study explores the association between these behaviors and HIV testing utilization among AGYW (aged 15-24) in Kibra Sub County, Nairobi.</p> <p><strong>Methods: </strong>A cross-sectional study sampled 379 AGYW from three wards in Kibra Sub County in Nairobi County. To be an eligible participant, one must have been a resident for at least one year before the time of the study and aged between 15-24 years, employing standardized structured interviewer-administered questionnaires and statistical analyses. Results were analyzed using Chi-square tests and logistic regression. Data was collected between June to July 2023.</p> <p><strong>Results: </strong>Overall, HIV testing prevalence was 60.7% (n=230). Those aged 20-24 were 71.3% (n=164), with secondary education were 63.5% (n=146) and married 28.7% (66) were more likely to undergo testing. Participants engaging in risky behaviors such as lack of condom use (3.96 times more likely), experiencing gender-based violence (4.65 times more likely), or contracting STIs (2.85 times more likely) had higher odds of seeking HIV testing services.</p> <p><strong>Conclusion: </strong>This study establishes a clear link between risky sexual behaviors and HIV testing among AGYW, with a 60.7% testing prevalence; however, gaps still exist. Efforts to enhance testing rates are vital. Interventions should align with acceptable methods, focusing on this high-risk group to ensure effective HIV care and prevention.</p>

opencc-zeroMay 2024View details →
zenodo36/100

Association between decreased ovarian reserve and poor oocyte quality in young women.

<p>Young women may present with decreased ovarian reserve (DOR) and/or poor oocyte quality. These may lead to poor reproductive outcomes. Our retrospective study evaluated the association between oocyte quality and ovarian reserve in women aged between 18 and 35 years and undergoing controlled ovarian stimulation (COS) for in vitro fertilization. We defined DOR when anti-M&uuml;llerian hormone (AMH) levels were &lt;1.2 ng/mL, basal follicle stimulating hormone (FSH) levels were &ge;10 mIU/mL, or the antral follicle count (AFC) was &lt;10 and analyzed the association between the number of mature or immature oocytes and the presence of alterations in oocyte morphology. We also evaluated the association between gonadotropin dose used in COS and oocyte quality. The study included 49 patients with a mean age of 31.0 &plusmn; 3.3 years; 348 oocyte images were evaluated. Patients with basal FSH levels of &lt;10 mIU/mL had more mature oocytes than the group of patients with elevated FSH levels (6 vs. 2; p &lt; 0.001). Patients with AMH&lt;1.2 ng/mL had fewer mature oocytes and increased basal FSH levels (p &lt; 0.001). Each unit increase in serum basal FSH levels represented a 42% increase in the likelihood of having an oocyte with cytoplasm abnormality (p = 0.006), while patients with AMH levels of &lt;1.2 ng/mL had 5.3 times the risk of having an oocyte with cytoplasm abnormality [p = 0.004] and were 3 times more likely to have an abnormality in the perivitelline space (p = 0.018). When the AFC was &lt;10, an increased risk of abnormally shaped oocytes was observed (p = 0.035). In summary, DOR was associated with poorer quality oocytes in women up to 35 years of age who underwent COS.</p>

opencc-by-4.0Oct 2018View details →
ClinicalTrials.gov36/100

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

ClinicalTrials.gov study NCT04758390. IPD Sharing: YES. Countries: 1. Publications: 7.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study

ClinicalTrials.gov study NCT02732730. IPD Sharing: NO. Countries: 2. Publications: 11.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

ClinicalTrials.gov study NCT00786409. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches

ClinicalTrials.gov study NCT04812795. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

HerpeVac Trial for Young Women

ClinicalTrials.gov study NCT00057330. IPD Sharing: Not stated. Countries: 2. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Reaching Adolescent Girls and Young Women Through Girl-Friendly Drug Vendors

ClinicalTrials.gov study NCT04045912. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Exercise, IMA and Sulfhydryl Biomarkers in Young Women

ClinicalTrials.gov study NCT07181044. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug Shopkeepers

ClinicalTrials.gov study NCT05525533. IPD Sharing: YES. Countries: 1. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Alignment of PrEP Use With HIV Risk in Young Women and Men

ClinicalTrials.gov study NCT04664998. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil

ClinicalTrials.gov study NCT00518336. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

ClinicalTrials.gov study NCT03803683. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Intervening on Women's Health for Rural Young Breast Cancer Survivors

ClinicalTrials.gov study NCT05414812. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA

ClinicalTrials.gov study NCT05504954. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES

ClinicalTrials.gov study NCT04376346. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

ClinicalTrials.gov study NCT04994509. IPD Sharing: NO. Countries: 2. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

ClinicalTrials.gov study NCT03018366. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record